Review of the current evidence on the invasive treatment of severe aortic stenosis in asymptomatic patients, with special emphasis on the results from the EVOLVED and EARLY-TAVR trials.
Analysis of the MATTERHORN trial on the efficacy and safety of two therapeutic approaches for treating secondary mitral regurgitation in patients with heart failure and optimal medical therapy: transcatheter edge-to-edge repair and mitral valve surgery (repair or replacement).
Analysis of evidence on the optimal timing for performing percutaneous coronary intervention (PCI) in TAVI candidates, along with an outline of the TAVI-PCI study protocol.
Updated results on the Melody bovine jugular vein bioprosthesis as a strategy to gain time before definitive prosthetic valve replacement in pediatric patients with non-repairable mitral regurgitation.
This commentary addresses a comprehensive review on the current management of secondary mitral regurgitation (sMR).
This prospective, multicenter, single-arm clinical trial evaluates the efficacy and safety of the 15-mm St. Jude Medical Masters HP® mechanical mitral valve over five years in pediatric patients under five years of age.
A retrospective single-center analysis of preoperative status and surgical outcomes in men versus women for all patients undergoing surgery for degenerative mitral regurgitation over 9 years.
The German CAMPAIGN registry outcomes focused on comparing morbidity and mortality in patients with infective endocarditis (IE) complicated by septic cerebral embolism (SCE) versus those without it.
Commentary by the expert Dr. Elisabet Berastegui on the role of minimally invasive surgery combined with sutureless bioprostheses in the current context.
Analysis of the NOTION 3 Study and Its Implications for the Treatment Allocation of Patients with Severe Aortic Stenosis and Concomitant Coronary Artery Disease
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.